Compare $ENSC vs $PHIO | Chartloom

Compare

$ENSC vs $PHIO

Ensysce Biosciences Inc · Phio Pharmaceuticals Corp

ENSC

Ensysce Biosciences Inc

PHIO

Phio Pharmaceuticals Corp

Compare $ENSC vs $PHIO

Comparing Ensysce Biosciences Inc and Phio Pharmaceuticals Corp

ENSCEnsysce Biosciences Inc

PHIOPhio Pharmaceuticals Corp

ENSCEnsysce Biosciences Inc

Market cap

$8M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-39.3%

YTD performance

-43.9%

52W performance

-78.6%

FCF yield

-116.0%

PHIOPhio Pharmaceuticals Corp

Market cap

$11M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-10.2%

52W performance

-59.6%

FCF yield

-107.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ENSC

PHIO

Detailed metrics comparison

ENSC

Ensysce Biosciences Inc

PHIO

Phio Pharmaceuticals Corp

Market Cap

ENSC$8M

PHIO$11M

Enterprise Value

ENSC$7M

PHIO$-2M

Price

ENSC$0.53

PHIO$0.98

P/E Ratio

ENSCN/A

PHION/A

P/S Ratio

ENSC1.72x

PHIO81.74x

EV/Sales

ENSC1.61x

PHIO-11.08x

EV/EBITDA

ENSC0.00x

PHIO0.00x

P/B Ratio

ENSC2.39x

PHIO0.91x

P/FCF Ratio

ENSCN/A

PHION/A

EV/FCF

ENSC-0.81x

PHIO0.13x

PEG Ratio

ENSCN/A

PHION/A

Forward P/E (NTM)

ENSCN/A

PHION/A

Forward P/S (NTM)

ENSCN/A

PHION/A

Revenue (TTM)

ENSC$5M

PHIO$0

Revenue Growth (YoY)

ENSC-39.3%

PHION/A

Forward Rev Growth

ENSC-45.7%

PHIO0.0%

Gross Margin (TTM)

ENSC0.0%

PHIO0.0%

Operating Margin (TTM)

ENSC0.0%

PHIO0.0%

EBITDA Margin (TTM)

ENSC-197.8%

PHIO0.0%

Net Margin (TTM)

ENSC-280.5%

PHIO0.0%

FCF Margin (TTM)

ENSC-199.5%

PHION/A

Net Income (TTM)

ENSC$-13M

PHIO$-13M

FCF (TTM)

ENSC$-9M

PHIO$-12M

EPS (TTM)

ENSC-$0.97

PHIO-$1.11

ROE (TTM)

ENSC-37496.0%

PHIO-8741.0%

ROA (TTM)

ENSC-32046.0%

PHIO-7976.0%

ROIC (TTM)

ENSC-33277.0%

PHIO-8741.0%

Cash

ENSC$677K

PHIO$13M

Debt

ENSC$197K

PHIO$0

Net Cash/Debt

ENSC$480K

PHIO$13M

Current Ratio (TTM)

ENSC0.70x

PHIO8.39x

Quick Ratio (TTM)

ENSC0.37x

PHIO7.62x

Debt/Equity (TTM)

ENSC0.10x

PHIO0.00x

Debt/Assets (TTM)

ENSC0.0%

PHIO0.0%

Interest Coverage (TTM)

ENSCN/A

PHION/A

Net Debt/EBITDA (TTM)

ENSC0.00x

PHIO0.00x

Beta

ENSC1.10

PHIO0.90

52W Performance

ENSC-78.6%

PHIO-59.6%

YTD Performance

ENSC-43.9%

PHIO-10.2%

% from 52W High

ENSC-80.8%

PHIO-76.6%

% from 52W Low

ENSC129.1%

PHIO20.8%

Asset Turnover (TTM)

ENSC1.14x

PHIO0.02x

FCF Yield (TTM)

ENSC-116.0%

PHIO-107.3%

Earnings Yield (TTM)

ENSC-163.1%

PHIO-113.5%

Dividend Yield (TTM)

ENSCN/A

PHION/A

Rule of 40

ENSC-238.8

PHIO0.0

EV/GP/RG

ENSCN/A

PHION/A

Ticker research

View ENSC research View PHIO research

Metric	ENSC Ensysce Biosciences Inc	PHIO Phio Pharmaceuticals Corp
Market & Valuation
Market Cap	$8M	$11M
Enterprise Value	$7M	$-2M
Price	$0.53	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	1.72x	81.74x
EV/Sales	1.61x	-11.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.39x	0.91x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.81x	0.13x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	-39.3%	N/A
Forward Rev Growth	-45.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-197.8%	0.0%
Net Margin (TTM)	-280.5%	0.0%
FCF Margin (TTM)	-199.5%	N/A
Net Income (TTM)	$-13M	$-13M
FCF (TTM)	$-9M	$-12M
EPS (TTM)	-$0.97	-$1.11
ROE (TTM)	-37496.0%	-8741.0%
ROA (TTM)	-32046.0%	-7976.0%
ROIC (TTM)	-33277.0%	-8741.0%
Financial Health
Cash	$677K	$13M
Debt	$197K	$0
Net Cash/Debt	$480K	$13M
Current Ratio (TTM)	0.70x	8.39x
Quick Ratio (TTM)	0.37x	7.62x
Debt/Equity (TTM)	0.10x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.10	0.90
52W Performance	-78.6%	-59.6%
YTD Performance	-43.9%	-10.2%
% from 52W High	-80.8%	-76.6%
% from 52W Low	129.1%	20.8%
Efficiency & Yields
Asset Turnover (TTM)	1.14x	0.02x
FCF Yield (TTM)	-116.0%	-107.3%
Earnings Yield (TTM)	-163.1%	-113.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-238.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ENSC research	View PHIO research

Valuation

P/S Ratio

ENSC

1.72x

PHIO

81.74x

EV/FCF

ENSC

-0.81x

PHIO

0.13x

Growth & revenue

Revenue Growth TTM

ENSC

-39.3%

Forward Revenue Growth

PHIO

0.0%

ENSC

-45.7%

Profitability & performance

Gross Margin

ENSC

0.0%

PHIO

0.0%

ROE

PHIO

-8741.0%

ENSC

-37496.0%

FCF Yield %

PHIO

-107.3%

ENSC

-116.0%

52-Week Performance

PHIO

-59.6%

ENSC

-78.6%

Detailed metrics comparison

ENSC

Ensysce Biosciences Inc

PHIO

Phio Pharmaceuticals Corp

Market Cap

ENSC$8M

PHIO$11M

Enterprise Value

ENSC$7M

PHIO$-2M

Price

ENSC$0.53

PHIO$0.98

P/E Ratio

ENSCN/A

PHION/A

P/S Ratio

ENSC1.72x

PHIO81.74x

EV/Sales

ENSC1.61x

PHIO-11.08x

EV/EBITDA

ENSC0.00x

PHIO0.00x

P/B Ratio

ENSC2.39x

PHIO0.91x

P/FCF Ratio

ENSCN/A

PHION/A

EV/FCF

ENSC-0.81x

PHIO0.13x

PEG Ratio

ENSCN/A

PHION/A

Forward P/E (NTM)

ENSCN/A

PHION/A

Forward P/S (NTM)

ENSCN/A

PHION/A

Revenue (TTM)

ENSC$5M

PHIO$0

Revenue Growth (YoY)

ENSC-39.3%

PHION/A

Forward Rev Growth

ENSC-45.7%

PHIO0.0%

Gross Margin (TTM)

ENSC0.0%

PHIO0.0%

Operating Margin (TTM)

ENSC0.0%

PHIO0.0%

EBITDA Margin (TTM)

ENSC-197.8%

PHIO0.0%

Net Margin (TTM)

ENSC-280.5%

PHIO0.0%

FCF Margin (TTM)

ENSC-199.5%

PHION/A

Net Income (TTM)

ENSC$-13M

PHIO$-13M

FCF (TTM)

ENSC$-9M

PHIO$-12M

EPS (TTM)

ENSC-$0.97

PHIO-$1.11

ROE (TTM)

ENSC-37496.0%

PHIO-8741.0%

ROA (TTM)

ENSC-32046.0%

PHIO-7976.0%

ROIC (TTM)

ENSC-33277.0%

PHIO-8741.0%

Cash

ENSC$677K

PHIO$13M

Debt

ENSC$197K

PHIO$0

Net Cash/Debt

ENSC$480K

PHIO$13M

Current Ratio (TTM)

ENSC0.70x

PHIO8.39x

Quick Ratio (TTM)

ENSC0.37x

PHIO7.62x

Debt/Equity (TTM)

ENSC0.10x

PHIO0.00x

Debt/Assets (TTM)

ENSC0.0%

PHIO0.0%

Interest Coverage (TTM)

ENSCN/A

PHION/A

Net Debt/EBITDA (TTM)

ENSC0.00x

PHIO0.00x

Beta

ENSC1.10

PHIO0.90

52W Performance

ENSC-78.6%

PHIO-59.6%

YTD Performance

ENSC-43.9%

PHIO-10.2%

% from 52W High

ENSC-80.8%

PHIO-76.6%

% from 52W Low

ENSC129.1%

PHIO20.8%

Asset Turnover (TTM)

ENSC1.14x

PHIO0.02x

FCF Yield (TTM)

ENSC-116.0%

PHIO-107.3%

Earnings Yield (TTM)

ENSC-163.1%

PHIO-113.5%

Dividend Yield (TTM)

ENSCN/A

PHION/A

Rule of 40

ENSC-238.8

PHIO0.0

EV/GP/RG

ENSCN/A

PHION/A

Ticker research

View ENSC research View PHIO research

Metric	ENSC Ensysce Biosciences Inc	PHIO Phio Pharmaceuticals Corp
Market & Valuation
Market Cap	$8M	$11M
Enterprise Value	$7M	$-2M
Price	$0.53	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	1.72x	81.74x
EV/Sales	1.61x	-11.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.39x	0.91x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.81x	0.13x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	-39.3%	N/A
Forward Rev Growth	-45.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-197.8%	0.0%
Net Margin (TTM)	-280.5%	0.0%
FCF Margin (TTM)	-199.5%	N/A
Net Income (TTM)	$-13M	$-13M
FCF (TTM)	$-9M	$-12M
EPS (TTM)	-$0.97	-$1.11
ROE (TTM)	-37496.0%	-8741.0%
ROA (TTM)	-32046.0%	-7976.0%
ROIC (TTM)	-33277.0%	-8741.0%
Financial Health
Cash	$677K	$13M
Debt	$197K	$0
Net Cash/Debt	$480K	$13M
Current Ratio (TTM)	0.70x	8.39x
Quick Ratio (TTM)	0.37x	7.62x
Debt/Equity (TTM)	0.10x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.10	0.90
52W Performance	-78.6%	-59.6%
YTD Performance	-43.9%	-10.2%
% from 52W High	-80.8%	-76.6%
% from 52W Low	129.1%	20.8%
Efficiency & Yields
Asset Turnover (TTM)	1.14x	0.02x
FCF Yield (TTM)	-116.0%	-107.3%
Earnings Yield (TTM)	-163.1%	-113.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-238.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ENSC research	View PHIO research